DIPYRIDAMOLE FOR INJECTION SOLUTION

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

DIPYRIDAMOLE

Beszerezhető a:

NOVOPHARM LIMITED

ATC-kód:

B01AC07

INN (nemzetközi neve):

DIPYRIDAMOLE

Adagolás:

5MG

Gyógyszerészeti forma:

SOLUTION

Összetétel:

DIPYRIDAMOLE 5MG

Az alkalmazás módja:

INTRAVENOUS

db csomag:

10 ML

Recept típusa:

Prescription

Terápiás terület:

MISCELLANEOUS VASODILATATING AGENTS

Termék összefoglaló:

Active ingredient group (AIG) number: 0106621005; AHFS:

Engedélyezési státusz:

CANCELLED POST MARKET

Engedély dátuma:

2018-05-07

Termékjellemzők

PRODUCT MONOGRAPH
Pr
NOVO-DIPIRADOL (dipyridamole) 25, 50, 75, 100 mg Tablets
Pr
DIPYRIDAMOLE FOR INJECTION (dipyridamole) 5 mg/mL, USP
Coronary Vasodilator
Inhibitor of Platelet Adhesion and Aggregation
Novopharm Limited
Date of Preparation:
30 Novopharm Court
October 26, 2006
Toronto, Ontario
M1B 2K9
Control No. 107491
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................
3
INDICATIONS AND CLINICAL
USE.....................................................................................
3
CONTRAINDICATIONS
..........................................................................................................
3
WARNINGS AND
PRECAUTIONS.........................................................................................
4
ADVERSE
REACTIONS...........................................................................................................
5
DRUG INTERACTIONS
...........................................................................................................
8
DOSAGE AND
ADMINISTRATION.......................................................................................
9
OVERDOSAGE
.........................................................................................................................
9
ACTION AND CLINICAL PHARMACOLOGY
................................................................... 10
STORAGE AND
STABILITY.................................................................................................
11
SPECIAL HANDLING INSTRUCTIONS
..............................................................................
11
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................... 11
PART II: SCIENTIFIC INFORMATION
...............................................................................
13
PHARMACEUTICAL
INFORMATION.........................................................